Literature DB >> 22822247

Semiparametric methods for evaluating risk prediction markers in case-control studies.

Ying Huang1, Margaret Sullivan Pepe.   

Abstract

The performance of a well-calibrated risk model for a binary disease outcome can be characterized by the population distribution of risk and displayed with the predictiveness curve. Better performance is characterized by a wider distribution of risk, since this corresponds to better risk stratification in the sense that more subjects are identified at low and high risk for the disease outcome. Although methods have been developed to estimate predictiveness curves from cohort studies, most studies to evaluate novel risk prediction markers employ case-control designs. Here we develop semiparametric methods that accommodate case-control data. The semiparametric methods are flexible, and naturally generalize methods previously developed for cohort data. Applications to prostate cancer risk prediction markers illustrate the methods.

Entities:  

Year:  2009        PMID: 22822247      PMCID: PMC3372083          DOI: 10.1093/biomet/asp040

Source DB:  PubMed          Journal:  Biometrika        ISSN: 0006-3444            Impact factor:   2.445


  10 in total

Review 1.  Phases of biomarker development for early detection of cancer.

Authors:  M S Pepe; R Etzioni; Z Feng; J D Potter; M L Thompson; M Thornquist; M Winget; Y Yasui
Journal:  J Natl Cancer Inst       Date:  2001-07-18       Impact factor: 13.506

2.  Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Authors:  Ian M Thompson; Donna Pauler Ankerst; Chen Chi; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Ziding Feng; Howard L Parnes; Charles A Coltman
Journal:  J Natl Cancer Inst       Date:  2006-04-19       Impact factor: 13.506

3.  Integrating the predictiveness of a marker with its performance as a classifier.

Authors:  Margaret S Pepe; Ziding Feng; Ying Huang; Gary Longton; Ross Prentice; Ian M Thompson; Yingye Zheng
Journal:  Am J Epidemiol       Date:  2007-11-02       Impact factor: 4.897

Review 4.  How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design.

Authors:  David F Ransohoff
Journal:  J Clin Epidemiol       Date:  2007-09-24       Impact factor: 6.437

5.  Evaluating the predictiveness of a continuous marker.

Authors:  Ying Huang; Margaret Sullivan Pepe; Ziding Feng
Journal:  Biometrics       Date:  2007-05-08       Impact factor: 2.571

Review 6.  Roadmap for developing and validating therapeutically relevant genomic classifiers.

Authors:  Richard Simon
Journal:  J Clin Oncol       Date:  2005-09-06       Impact factor: 44.544

7.  A parametric ROC model-based approach for evaluating the predictiveness of continuous markers in case-control studies.

Authors:  Y Huang; M S Pepe
Journal:  Biometrics       Date:  2009-12       Impact factor: 2.571

8.  Smoothing reference centile curves: the LMS method and penalized likelihood.

Authors:  T J Cole; P J Green
Journal:  Stat Med       Date:  1992-07       Impact factor: 2.373

9.  Markers for early detection of cancer: statistical guidelines for nested case-control studies.

Authors:  Stuart G Baker; Barnett S Kramer; Sudhir Srivastava
Journal:  BMC Med Res Methodol       Date:  2002-02-28       Impact factor: 4.615

10.  Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design.

Authors:  Margaret S Pepe; Ziding Feng; Holly Janes; Patrick M Bossuyt; John D Potter
Journal:  J Natl Cancer Inst       Date:  2008-10-07       Impact factor: 13.506

  10 in total
  9 in total

1.  Assessing risk prediction models in case-control studies using semiparametric and nonparametric methods.

Authors:  Ying Huang; Margaret Sullivan Pepe
Journal:  Stat Med       Date:  2010-06-15       Impact factor: 2.373

2.  LOGISTIC REGRESSION ANALYSIS WITH STANDARDIZED MARKERS.

Authors:  Ying Huang; Margaret S Pepe; Ziding Feng
Journal:  Ann Appl Stat       Date:  2013-09-01       Impact factor: 2.083

3.  Semiparametric methods for evaluating the covariate-specific predictiveness of continuous markers in matched case-control studies.

Authors:  Y Huang; M S Pepe
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2010       Impact factor: 1.864

4.  Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ewout W Steyerberg
Journal:  Stat Med       Date:  2010-11-05       Impact factor: 2.373

5.  Estimating improvement in prediction with matched case-control designs.

Authors:  Aasthaa Bansal; Margaret Sullivan Pepe
Journal:  Lifetime Data Anal       Date:  2013-01-29       Impact factor: 1.588

6.  A parametric ROC model-based approach for evaluating the predictiveness of continuous markers in case-control studies.

Authors:  Y Huang; M S Pepe
Journal:  Biometrics       Date:  2009-12       Impact factor: 2.571

7.  Partial summary measures of the predictiveness curve.

Authors:  Michael C Sachs; Xiao-Hua Zhou
Journal:  Biom J       Date:  2013-03-18       Impact factor: 2.207

8.  The potential of genes and other markers to inform about risk.

Authors:  Margaret S Pepe; Jessie W Gu; Daryl E Morris
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02-16       Impact factor: 4.254

9.  More Accurate Oral Cancer Screening with Fewer Salivary Biomarkers.

Authors:  James Michael Menke; Md Shahidul Ahsan; Suan Phaik Khoo
Journal:  Biomark Cancer       Date:  2017-10-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.